Aldo Marmotti

Azienda Trasporti Milanesi (Italy)

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Elena Munarini

Fondazione IRCCS Istituto Nazionale dei Tumori

Roberto Boffi

Fondazione IRCCS Istituto Nazionale dei Tumori

Cinzia De Marco

Fondazione IRCCS Istituto Nazionale dei Tumori

Roberto Mazza

University of Pisa

Giovanni Invernizzi

Politecnico di Milano

Anna Gardiner

Cambridge University Hospitals NHS Foundation Trust

Paolo Pozzi

University of Modena and Reggio Emilia

Chiara Marabelli

Fondazione IRCCS Istituto Nazionale dei Tumori

Cooperative Institutions

Fondazione IRCCS Istituto Nazionale dei Tumori

Conference Board

University of Belgrade

The Maria Sklodowska-Curie National Research Institute of Oncology

IRCCS San Camillo Hospital

Uniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego

Lega Italiana per la Lotta ai Tumori

Società Italiana di Medicina Generale

Ambiente Italia (Italy)

University of Modena and Reggio Emilia

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Antismoking Centers in Milan's Communal Pharmacies: Analysis of the 2010–2011 Campaign

Tumori Journal (2013)

Elena Munarini Chiara Marabelli Aldo Marmotti Anna Gardiner Giovanni Invernizzi

Aims and background According to recent assessments from the Italian Istituto Superiore della Sanità, information and assistance to smokers are still far from satisfactory. We evaluated the impact of a new smoking cessation service located in pharmacies. Smokers' individual characteristics were also considered. Material and Methods A 1-year pilot study was carried out from October 2010 to September 2011. Five pharmacies in Milan were selected. A psychologist with experience in smoking cessation was present in each pharmacy one afternoon per week, and pharmacists were trained by a team from the Antismoking Center of the Fondazione IRCCS Istituto Nazionale dei Tumori. Each pharmacy was equipped with informative material, carbon monoxide analyzers, and motivational and nicotine dependence questionnaires, in addition to a clinical briefcase. Counseling sessions were also arranged upon request. Results In the first 12 months of activity, 216 persons asked for a consultation. The sample, aged 15–79 years, reported the following median values: 30 pack/years, 14 ppm CO, and a Fagerström Test of Nicotine Dependence score of 5. More than one-third of the sample (40.3%) had one pathology and 25% had more than one. In some cases (15.7%), people just wanted information about what the service offered. For those who tried to quit, smoking cessation rates were 33.3% at 3 months, 28% at 6 months, and 24.6% at 1 year. Three kinds of pharmacologic therapies were suggested to smokers: nicotine replacement therapy (75.5%), varenicline (17.5%), and bupropion (7%). Conclusions The results show that an accessible and free smoking cessation service is considered useful by smokers as demonstrated by the large number of requests compared with other smoking centers in Italy. Increased involvement of pharmacists in supporting smoking cessation makes this a promising initiative for the near future.

Varenicline

Nicotine replacement therapy

10.1177/030089161309900503

Cite

Citations (4)

Making smoking cessation easier and closer the smoker: The results of Milan study of antismoking centers in pharmacies

Elena Munarini Aldo Marmotti Anna Gardiner Giovanni Invernizzi Roberto Mazza

Background: - A few strong inputs from the Italian Institute of Health indicate that information and assistance to smokers are still far from being satisfactory. Aims: - To verify if offering smoking cessation at the pharmacy, a health facility where smokers have often the chance to stop, can promote the participation to cessation programs. Methods: - A 6-month pilot phase was carried out from October 2010 to March 2011. Five pharmacies in Milan were selected. Chemists were trained by the team of the Antismoking Center of the Istituto Nazionale dei Tumori (INT). Every pharmacy was equipped with informative material, CO analyzers, motivational and FTND's questionnaires and with a clinical briefcase; moreover a trained psychologist of INT collaborated with the chemist. Results: - In the first four months of activity 144 smokers (54% male, 46% females) asked for a consultation. The median values were: age 52 years, p/y 31, CO 14ppm, FTND's test 5. Regarding the pathologies, 25% of the smokers had cardiovascular and 11% respiratory diseases, 22% other pathologies, 43% declared they were “healthy” smokers. Overall, 45% of the smokers asked to stop smoking, 33% to reduce, 21% just wanted to get information. Conclusions: - The results show that the opportunity to have accessible and free smoking cessation service is considered useful by smokers. The great number of requests, together with the easy transferability of the project to other pharmacies, makes it a very promising initiative for the next future.

Chemist

Cite

Citations (0)

Antismoking centers in Milan's communal pharmacies: analysis of the 2010-2011 campaign.

Tumori Journal (2013)

Elena Munarini Chiara Marabelli Aldo Marmotti Anna Gardiner Giovanni Invernizzi

According to recent assessments from the Italian Istituto Superiore della Sanità, information and assistance to smokers are still far from satisfactory. We evaluated the impact of a new smoking cessation service located in pharmacies. Smokers' individual characteristics were also considered.A 1-year pilot study was carried out from October 2010 to September 2011. Five pharmacies in Milan were selected. A psychologist with experience in smoking cessation was present in each pharmacy one afternoon per week, and pharmacists were trained by a team from the Antismoking Center of the Fondazione IRCCS Istituto Nazionale dei Tumori. Each pharmacy was equipped with informative material, carbon monoxide analyzers, and motivational and nicotine dependence questionnaires, in addition to a clinical briefcase. Counseling sessions were also arranged upon request.In the first 12 months of activity, 216 persons asked for a consultation. The sample, aged 15-79 years, reported the following median values: 30 pack/years, 14 ppm CO, and a Fagerström Test of Nicotine Dependence score of 5. More than one-third of the sample (40.3%) had one pathology and 25% had more than one. In some cases (15.7%), people just wanted information about what the service offered. For those who tried to quit, smoking cessation rates were 33.3% at 3 months, 28% at 6 months, and 24.6% at 1 year. Three kinds of pharmacologic therapies were suggested to smokers: nicotine replacement therapy (75.5%), varenicline (17.5%), and bupropion (7%).The results show that an accessible and free smoking cessation service is considered useful by smokers as demonstrated by the large number of requests compared with other smoking centers in Italy. Increased involvement of pharmacists in supporting smoking cessation makes this a promising initiative for the near future.

Varenicline

Nicotine replacement therapy

Bupropion

10.1700/1377.15305

Cite

Citations (4)